Exchange: NASDAQ·Updated 07:59 PM EST

GOVX News

News
all
press releases
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. Geovax Labs (NASDAQ:GOVX) stock roseread more...
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-market session. The market value of their outstanding shares is at $14.8 million. Geovax Labs (NASDAQ:GOVX) stock roseread more...
Benzinga
More News
GeoVax Labs (GOVX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Zacks
GeoVax announced the discontinuation of its development of a COVID-19 vaccine candidate and also came out with a share resale plan.
Stocktwits
GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement, sparking dilution fears.read more...
Benzinga
CEO David A. Dodd said GEO-MVA remains central to GeoVax’s biodefense and vaccine supply strategy.
Stocktwits
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits
Among the four U.S.-listed pharma stocks, retail investors are ‘extremely bullish’ on Emergent Biosolutions as it expressed readiness to scale up response efforts for the WHO health emergency.
Stocktwits
The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.
Sponsored

Advertisement|Remove ads.